IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation Using Serial Biopsy Specimens

Background: Recurrence of hepatitis C virus (HCV) infection following orthotopic liver transplantation (OLT) is universal. There is paucity of data on the safety and efficacy of interleukin (IL)-2 receptor antagonist (IL-2RA) when added to the standard immunosuppression regimen in OLT recipients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanouneh, I. A., Zein, N. N., Lopez, R., Yerian, L., Fung, J., Eghtesad, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Organ Transplantation Institute 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089216/
https://www.ncbi.nlm.nih.gov/pubmed/25013557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089216/
https://www.ncbi.nlm.nih.gov/pubmed/25013557

Ejemplares similares